AB-1002
- Generic Name
- AB-1002
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
- First Posted Date
- 2022-10-28
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- AskBio Inc
- Target Recruit Count
- 150
- Registration Number
- NCT05598333
- Locations
- 🇳🇱
Erasmus Medisch Centrum, Rotterdam, Netherlands
🇪🇸Hospital Universitario de Bellvitge, Barcelona, Catalogna, Spain
🇺🇸Cardiology P.C. Birmingham, Birmingham, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath